Memorial Sloan Kettering Cancer Center Commack — Commack, New York

Memorial Sloan Kettering Cancer Center Commack is a clinical research site located in Commack, New York, United States 11725.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center Commack has participated in 10 clinical trials with 4 currently active.

Therapeutic areas: Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, Pfizer, Beth Israel Deaconess Medical Center.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center Commack?

Memorial Sloan Kettering Cancer Center Commack has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center Commack conducted?

Memorial Sloan Kettering Cancer Center Commack has 10 clinical trials on record, with 4 currently active. Their work covers Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer.

Is Memorial Sloan Kettering Cancer Center Commack accredited by Crixeo Health?

Yes — Memorial Sloan Kettering Cancer Center Commack holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center Commack?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.